Should the patient be switched from sotalol 80 mg twice daily to bisoprolol because of a QTc interval of 500 ms?

Discontinue Sotalol Immediately - QTc of 500 ms Mandates Action

With a QTc of 500 ms on sotalol 80 mg twice daily, you must either reduce the dose or discontinue the drug entirely according to FDA labeling. Switching to bisoprolol is a reasonable alternative if beta-blockade is still needed for rate control or other indications, but the primary concern is addressing the dangerous QT prolongation.

Critical FDA Guidance on QTc ≥500 ms

The FDA label for sotalol is unequivocal: if QTc reaches ≥500 ms during treatment, the dose must be reduced and the patient carefully monitored until QTc returns to <520 ms 1. Since this patient is already on the lowest maintenance dose (80 mg twice daily), and the QTc has reached the critical threshold of 500 ms, discontinuation is the safest course of action per FDA guidance 1.

Why This Matters for Mortality

• Torsades de pointes risk: QTc ≥500 ms significantly increases the risk of life-threatening polymorphic ventricular tachycardia (torsades de pointes), which can be fatal 1
• The FDA specifically states that if QTc is ≥520 ms while on the lowest maintenance dose (80 mg), the drug should be discontinued 1
• At 500 ms, you're at the threshold where serious proarrhythmic events become concerning

The Decision Algorithm

Step 1: Immediate action on sotalol

• Stop sotalol immediately given QTc = 500 ms on lowest dose
• Recheck ECG within 24-48 hours to confirm QTc normalization
• Assess for other QT-prolonging medications and electrolyte abnormalities (hypokalemia, hypomagnesemia)

Step 2: Evaluate need for alternative therapy

• If beta-blockade is needed for rate control in atrial fibrillation: bisoprolol is appropriate
• If antiarrhythmic therapy is needed for rhythm control: consider alternative agents (amiodarone, dofetilide with appropriate monitoring, or catheter ablation)
• If this was for ventricular arrhythmias: reassess with electrophysiology for alternative strategies

Step 3: Bisoprolol initiation if chosen

• Start bisoprolol 2.5-5 mg daily
• Bisoprolol does NOT prolong QT interval significantly
• According to 2023 Canadian guidelines, bisoprolol is better tolerated than non-selective beta-blockers and is appropriate for lower-risk patients, though it lacks the Class III antiarrhythmic properties of sotalol 2
• Recheck ECG after starting bisoprolol to confirm QTc normalization

Important Caveats

Bisoprolol is NOT equivalent to sotalol for arrhythmia suppression: Sotalol has both beta-blocking (Class II) and potassium channel blocking (Class III) properties. Bisoprolol only provides beta-blockade. If the patient was on sotalol specifically for rhythm control of atrial fibrillation or ventricular arrhythmias, simply switching to bisoprolol may result in arrhythmia recurrence 2.

Context matters for the switch:

• If sotalol was used primarily for rate control in permanent atrial fibrillation: bisoprolol is a suitable alternative
• If sotalol was used for rhythm control in paroxysmal/persistent atrial fibrillation: you'll need a different antiarrhythmic strategy, not just bisoprolol
• If sotalol was used for ventricular arrhythmias: bisoprolol alone is insufficient; consider amiodarone or ICD evaluation

Monitor for late QT prolongation: Recent data shows that QT prolongation can occur even after the initial loading period, with some cases appearing months to years later 3. This reinforces that the current QTc of 500 ms represents a genuine safety concern requiring immediate action.

What NOT to Do

• Do not simply reduce sotalol dose: At 80 mg twice daily, you're already at the lowest standard dose, and the FDA guidance suggests discontinuation at this point 1
• Do not continue sotalol "with monitoring": QTc of 500 ms is the action threshold, not a "watch and wait" value
• Do not assume bisoprolol will provide equivalent arrhythmia control: It won't - it's only a beta-blocker without Class III effects 2